Correlation between expression of epidermal growth factor receptor and adverse reactions after chemotherapy of advanced non-small-cell lung cancer

about

Correlation between expression of epidermal growth factor receptor and adverse reactions after chemotherapy of advanced non-small-cell lung cancer

Item

http://www.wikidata.org/entity/Q36270116

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Correlation between expression ...... ced non-small-cell lung cancer

@ast

Correlation between expression ...... ced non-small-cell lung cancer

@en

type

Item

label

Correlation between expression ...... ced non-small-cell lung cancer

@ast

Correlation between expression ...... ced non-small-cell lung cancer

@en

prefLabel

Correlation between expression ...... ced non-small-cell lung cancer

@ast

Correlation between expression ...... ced non-small-cell lung cancer

@en

P1476

Correlation between expression ...... ced non-small-cell lung cancer

@en

P2093

Chunyan Tian

http://www.w3.org/2001/XMLSchema#string

Futang Yang

http://www.w3.org/2001/XMLSchema#string

Jihong Zhang

http://www.w3.org/2001/XMLSchema#string

Zerui Hao

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.

A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations.

Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients.

Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples

Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.

Clinical and metabolic parameters in non-small cell lung carcinoma and colorectal cancer patients with and without KRAS mutations.

XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer.

Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer.

P304

1115-1120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12669/PJMS.315.7939

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26648997

http://www.w3.org/2001/XMLSchema#string

P932

4641266

http://www.w3.org/2001/XMLSchema#string